| |FGT| [cm3] | FGT % [ %] | |BPE| SUB 1 [cm3] | BPE % SUB 1 [ %] | |BPE| SUB 3 [cm3] | BPE % SUB 3 [ %] | |
---|---|---|---|---|---|---|---|
44 women who did not develop breast cancer post-RRSO | Pre-RRSO | 83.2 ± 63.8 | 11.3 ± 8.1 | 28.2 ± 44.2 | 3.8 ± 4.5 | 43.0 ± 49.7 | 6.0 ± 5.9 |
Post-RRSO | 60.4 ± 50.1 | 10.3 ± 7.5 | 12.2 ± 11.8 | 2.3 ± 1.8 | 21.0 ± 15.2 | 3.9 ± 2.5 | |
P value | 0.005 | 0.23 | 0.027 | 0.045 | 0.005 | 0.015 | |
FDR-corrected P value | 0.03 | 0.34 | 0.06 | 0.078 | 0.03 | 0.046 | |
6 women who developed breast cancer post-RRSO | Pre-RRSO | 65.1 ± 60.2 | 11.6 ± 3.8 | 26.7 ± 12.6 | 7.3 ± 4.6 | 40.0 ± 31.3 | 8.2 ± 3.8 |
Post-RRSO | 72.9 ± 38.2 | 11.2 ± 7.6 | 20.5 ± 19.2 | 3.3 ± 2.3 | 33.6 ± 20.1 | 5.4 ± 3.2 | |
P value | 0.78 | 0.83 | 0.48 | 0.035 | 0.68 | 0.0096 | |
FDR-corrected P value | 0.83 | 0.83 | 0.64 | 0.070 | 0.82 | 0.038 | |
ANOVA P-value | 0.83 | 0.24 | 0.058 | 0.0057 | 0.021 | 0.023 | |
FDR-corrected ANOVA P-value | 0.83 | 0.29 | 0.087 | 0.034 | 0.046 | 0.046 | |
AUC | 0.66 | 0.57 | 0.48 | 0.78 | 0.66 | 0.65 |